Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy : The PD MED Randomized Clinical Trial
Citation
Gray , R , Patel , S , Ives , N , Rick , C , Woolley , R , Muzerengi , S , Gray , A , Jenkinson , C , McIntosh , E , Wheatley , K , Williams , A , Clarke , C E & PD MED Collaborative Group 2021 , ' Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy : The PD MED Randomized Clinical Trial ' , JAMA Neurology , vol. 79 , no. 2 , pp. 131-140 . https://doi.org/10.1001/jamaneurol.2021.4736
Rights
This is an open access article distributed under the terms of the CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium. You are not required to obtain permission to reuse this article content, provided that you credit the author and journal. If you are the author of this article and have questions about the Creative Commons license, please contact permissions@jamanetwork.com.